{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {"h" : "Thanksgiving Day"}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
prnewswire

Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009

  • Press Release
  • Source: Cambrex Corporation
  • On 1:36 pm EDT, Tuesday October 27, 2009

EAST RUTHERFORD, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM - News) announced that third quarter 2009 financial results will be released on Tuesday, November 3, 2009 after the market closes.

Related Quotes

SymbolPriceChange
CBM5.64-0.17
Chart for CAMBREX CP
{"s" : "cbm","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The Company will host a conference call to discuss the third quarter 2009 financial results.

                     Third Quarter 2009 Earnings Conference Call

    When:            Wednesday, November 4, 2009 at 8:30 a.m. Eastern Time

    Dial-in:         1-888-634-4003 for U.S.
                     1-706-634-6653 for International
                     Pass code:  37211896

    Dial-in Replay:  1-800-642-1687 for U.S.
                     1-706-645-9291 for International
                     Pass code:  37211896
                     Available through Wednesday, November 11, 2009

    Webcast:         www.cambrex.com
                     Available for 30 days following the conference call

About Cambrex

Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. For more information, please visit www.cambrex.com.

Related Headlines

Top Stories

Related Message Boards

Sponsored Links

Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.